CelerisAI is an AI/ML-guided drug discovery company. We combine advanced AI/ML with deep biology expertise to design novel therapeutics for high-unmet-need diseases across Inflammation & Pulmonary diseases, Cardiovascular (anti-thrombotic + vasodilators), and Oncology — faster, cheaper, and with dramatically higher probability of clinical success. Unlike most AI drug discovery companies that begin with the algorithm and search for the biology, we begin with the biology and deploy best-in-class AI/ML algorithms. Every pipeline program traces back to our founder's own academic and industry research. Our AI/ML stack: generative design, ADMET/PK/PD prediction (cuts costs >70%), target mining, and clinical outcome prediction. Let's partner to reimagine drug discovery. Reach out or visit our website. 🌐 celerisai.co.in | 📧 craval@celerisai.co.in #CelerisAI #DrugDiscovery #AIDrugDiscovery #PrecisionMedicine #TranslationalResearch #Biotech #Startup#Inflammation #Cardiovasculardiseases #Oncology #BiotechStartup #ArtificialIntellegence #AI #BDPartnerships #OpenToConnect
| Website | http://www.celerisai.co.in |
| Employees | 1 (1 on RocketReach) |
| Founded | 2026 |
| Industry | Biotechnology Research |
Looking for a particular CelerisAI employee's phone or email?
Chintan Raval is the Founder and CEO of CelerisAI.
1 people are employed at CelerisAI.